What were the percentages of patients undergoing mechanical thrombectomy in the Anterior Cerebral Artery (ACA) and Posterior Cerebral Artery (PCA) territories in the ESCAPE (Efficient Study of Contrast Agent and Post-thrombectomy Evaluation) trial?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Mechanical Thrombectomy in ACA and PCA Territories

  • The ESCAPE (Efficient Study of Contrast Agent and Post-thrombectomy Evaluation) trial is not directly mentioned in the provided studies.
  • However, study 1 discusses mechanical thrombectomy of acute distal posterior cerebral artery occlusions, which may be relevant to the PCA territory.
  • Study 2 analyzes mechanical thrombectomy in anterior circulation (AC) and posterior circulation (PC) large vessel occlusions, but does not provide specific percentages for the ACA and PCA territories.
  • Studies 3, 4, and 5 do not provide information on the specific percentages of patients undergoing mechanical thrombectomy in the ACA and PCA territories.

Available Data on Mechanical Thrombectomy

  • Study 2 reports that out of 137 patients, occlusion was found in the M1 segment (44.5%), carotid T occlusion (37.2%), and basilar artery (18.2%).
  • Study 1 includes 35 consecutive patients who underwent mechanical thrombectomy for acute distal PCA occlusion, with 25 patients (71.4%) having occlusions of the P2 segment and 10 patients (28.6%) having occlusions of the P3 segment.
  • Study 5 analyzes 184 patients who underwent mechanical thrombectomy or standard medical treatment for primary distal occlusion of the posterior cerebral artery (PCA) of the P2 or P3 segment.

Limitations of Available Data

  • The provided studies do not specifically report the percentages of patients undergoing mechanical thrombectomy in the ACA and PCA territories in the ESCAPE trial.
  • The available data may not be directly applicable to the ESCAPE trial, and more specific information may be required to answer the question accurately 2, 1, 3, 4, 5.

Related Questions

Is the distal P2 segment of the posterior cerebral artery (PCA) a dangerous location for endovascular mechanical thrombectomy?
What is the management for a patient with an acute infarct involving the posterior cerebral artery (PCA)?
What is the recommended management for an occlusion in the P2 (posterior cerebral artery segment 2) segment requiring thrombectomy?
What criteria do patients need to meet to most likely benefit from mechanical thrombectomy, as shown in randomized trials, such as evidence of salvageable brain tissue on advanced imaging, Modified Rankin Scale (MRS) score, National Institute of Health (NIH) Stroke Scale score, or presence of a large anterior circulation vessel occlusion?
What percentage of patients underwent thrombectomy in the Anterior Cerebral Artery (ACA) and Posterior Cerebral Artery (PCA) territories in the Distal trial?
What are the risks associated with using Tylenol (acetaminophen) in infants?
What are the blood pressure guidelines for aortic root dilation?
Does a patient with an increased risk of gastrointestinal rebleeding and a pre-endoscopy Rockall score of 1 require prostaglandins over Proton Pump Inhibitors (PPI)?
What antibiotic is recommended for treating Enterococcus faecalis (E. faecalis) urinary tract infection (UTI)?
What percentage of patients underwent thrombectomy in the Anterior Cerebral Artery (ACA) and Posterior Cerebral Artery (PCA) territories in the Distal trial?
How long to withhold Trulicity (dulaglutide) before EGD (Esophagogastroduodenoscopy) per GI (Gastrointestinal) guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.